Literature DB >> 31687921

O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee.

Rochelle F Andreotti1, Dirk Timmerman1, Lori M Strachowski1, Wouter Froyman1, Beryl R Benacerraf1, Genevieve L Bennett1, Tom Bourne1, Douglas L Brown1, Beverly G Coleman1, Mary C Frates1, Steven R Goldstein1, Ulrike M Hamper1, Mindy M Horrow1, Marta Hernanz-Schulman1, Caroline Reinhold1, Stephen L Rose1, Brad P Whitcomb1, Wendy L Wolfman1, Phyllis Glanc1.   

Abstract

The Ovarian-Adnexal Reporting and Data System (O-RADS) US risk stratification and management system is designed to provide consistent interpretations, to decrease or eliminate ambiguity in US reports resulting in a higher probability of accuracy in assigning risk of malignancy to ovarian and other adnexal masses, and to provide a management recommendation for each risk category. It was developed by an international multidisciplinary committee sponsored by the American College of Radiology and applies the standardized reporting tool for US based on the 2018 published lexicon of the O-RADS US working group. For risk stratification, the O-RADS US system recommends six categories (O-RADS 0-5), incorporating the range of normal to high risk of malignancy. This unique system represents a collaboration between the pattern-based approach commonly used in North America and the widely used, European-based, algorithmic-style International Ovarian Tumor Analysis (IOTA) Assessment of Different Neoplasias in the Adnexa model system, a risk prediction model that has undergone successful prospective and external validation. The pattern approach relies on a subgroup of the most predictive descriptors in the lexicon based on a retrospective review of evidence prospectively obtained in the IOTA phase 1-3 prospective studies and other supporting studies that assist in differentiating management schemes in a variety of almost certainly benign lesions. With O-RADS US working group consensus, guidelines for management in the different risk categories are proposed. Both systems have been stratified to reach the same risk categories and management strategies regardless of which is initially used. At this time, O-RADS US is the only lexicon and classification system that encompasses all risk categories with their associated management schemes. © RSNA, 2019.

Entities:  

Mesh:

Year:  2019        PMID: 31687921     DOI: 10.1148/radiol.2019191150

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  35 in total

1.  Uterine and ovarian cancer DFP report.

Authors: 
Journal:  Abdom Radiol (NY)       Date:  2021-02-04

2.  Diagnostic accuracy and inter-observer reliability of the O-RADS scoring system among staff radiologists in a North American academic clinical setting.

Authors:  Yeli Pi; Mitchell P Wilson; Prayash Katlariwala; Medica Sam; Thomas Ackerman; Lee Paskar; Vimal Patel; Gavin Low
Journal:  Abdom Radiol (NY)       Date:  2021-06-29

Review 3.  Multimodality imaging review of complex pelvic lesions in female pelvis.

Authors:  Anuradha Chandramohan; Tameem Ahmed Bhat; Reetu John; Betty Simon
Journal:  Br J Radiol       Date:  2020-09-04       Impact factor: 3.039

Review 4.  Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists.

Authors:  Malak Itani; Neeraj Lalwani; Dhakshinamoorthy Ganeshan; Maria Zulfiqar; Cary Siegel
Journal:  Abdom Radiol (NY)       Date:  2021-04-13

5.  Interreader Agreement and Intermodality Concordance of O-RADS US and MRI for Assessing Large, Complex Ovarian-Adnexal Cysts.

Authors:  Yang Guo; Catherine H Phillips; Krista Suarez-Weiss; Lauren A Roller; Mary C Frates; Carol B Benson; Atul B Shinagare
Journal:  Radiol Imaging Cancer       Date:  2022-09

Review 6.  Current update on malignant epithelial ovarian tumors.

Authors:  Sherif B Elsherif; Priya R Bhosale; Chandana Lall; Christine O Menias; Malak Itani; Kristina A Butler; Dhakshinamoorthy Ganeshan
Journal:  Abdom Radiol (NY)       Date:  2021-06-05

Review 7.  O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.

Authors:  Elizabeth A Sadowski; Isabelle Thomassin-Naggara; Andrea Rockall; Katherine E Maturen; Rosemarie Forstner; Priyanka Jha; Stephanie Nougaret; Evan S Siegelman; Caroline Reinhold
Journal:  Radiology       Date:  2022-01-18       Impact factor: 11.105

Review 8.  Ultrasound evaluation of ovarian masses and assessment of the extension of ovarian malignancy.

Authors:  Francesca Moro; Rosanna Esposito; Chiara Landolfo; Wouter Froyman; Dirk Timmerman; Tom Bourne; Giovanni Scambia; Lil Valentin; Antonia Carla Testa
Journal:  Br J Radiol       Date:  2021-06-09       Impact factor: 3.629

Review 9.  Ovary: MRI characterisation and O-RADS MRI.

Authors:  Elizabeth A Sadowski; Katherine E Maturen; Andrea Rockall; Caroline Reinhold; Helen Addley; Priyanka Jha; Nishat Bharwani; Isabelle Thomassin-Naggara
Journal:  Br J Radiol       Date:  2021-04-30       Impact factor: 3.629

Review 10.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Authors:  Dirk Timmerman; François Planchamp; Tom Bourne; Chiara Landolfo; Andreas du Bois; Luis Chiva; David Cibula; Nicole Concin; Daniela Fischerova; Wouter Froyman; Guillermo Gallardo Madueño; Birthe Lemley; Annika Loft; Liliana Mereu; Philippe Morice; Denis Querleu; Antonia Carla Testa; Ignace Vergote; Vincent Vandecaveye; Giovanni Scambia; Christina Fotopoulou
Journal:  Int J Gynecol Cancer       Date:  2021-06-10       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.